Indication
Open Angle or Ocular Hypertension
2 clinical trials
2 products
Product
BrinzolamideProduct
AzoptClinical trial
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSIONStatus: Completed, Estimated PCD: 2018-11-17